89 related articles for article (PubMed ID: 2230888)
1. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.
Tefferi A; Zellers RA; Banks PM; Therneau TM; Colgan JP
J Clin Oncol; 1990 Dec; 8(12):1959-65. PubMed ID: 2230888
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
Crennan E; D'Costa I; Liew KH; Thompson J; Laidlaw C; Cooper I; Quong G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):333-7. PubMed ID: 7530700
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
4. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
8. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
9. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
[TBL] [Abstract][Full Text] [Related]
10. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
11. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
12. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
Regula DP; Weiss LM; Warnke RA; Dorfman RF
Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
[TBL] [Abstract][Full Text] [Related]
15. Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease.
Tefferi A; Wiltsie JC; Kurtin PJ
Am J Hematol; 1992 Jul; 40(3):232-3. PubMed ID: 1609779
[TBL] [Abstract][Full Text] [Related]
16. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic study of lymphocyte predominance Hodgkin's disease.
Bishop PW; Harris M; Smith AP; Elsam KJ
Histopathology; 1991 Jan; 18(1):19-24. PubMed ID: 2013458
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
[TBL] [Abstract][Full Text] [Related]
20. The clinical relevance of L26, a B-cell-specific antibody, in Hodgkin's disease.
Molot RJ; Mendenhall NP; Barré DM; Braylan RC
Am J Clin Oncol; 1994 Jun; 17(3):185-8. PubMed ID: 7514847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
